Brecht Devleesschauwer

Mar 4, 2024 | jech.bmj.com | Lisa Cavillot |Brecht Devleesschauwer |Chloé Wyndham-Thomas |Herman Van Oyen

Discussion Although only 34% of the Belgian population stated that they were definitively ready to be vaccinated against COVID-19 before the start of the vaccination campaign, Belgium achieved the seventh highest vaccination coverage for the primary vaccination course in the European Union (with 89% of individuals over 18 years old having completed their primary course on 8 April 2022).15 16 22 Nevertheless, despite this high rate and free vaccination, important SD and SE disparities in...

Dec 26, 2023 | jech.bmj.com | Lisa Cavillot |Brecht Devleesschauwer |Chloé Wyndham-Thomas |Herman Van Oyen

Discussion Although only 34% of the Belgian population stated that they were definitively ready to be vaccinated against COVID-19 before the start of the vaccination campaign, Belgium achieved the seventh highest vaccination coverage for the primary vaccination course in the European Union (with 89% of individuals over 18 years old having completed their primary course on 8 April 2022).15 16 22 Nevertheless, despite this high rate and free vaccination, important SD and SE disparities in...

Mar 30, 2023 | baph.be | Brecht Devleesschauwer

On Thursday 8 June 2023, the Belgian Association for Public Health (BAPH) is organizing, in Louvain-la-Neuve (Aula Magna), the symposium:Public health in Belgium : Quo vadisWorking together on the challenges and future of public health in BelgiumThe morning of the symposium will be organized around four plenary sessions and a debate during which Belgian and international speakers will discuss public health challenges in Belgium and Europe.

Feb 9, 2023 | nature.com | Pavel Kolkhir |Marcus Maurer |Brecht Devleesschauwer

A rare disease is any type of disease that affects only a small proportion of the population. As of now, there is no consensus on an international definition of rare diseases1. In the European Union, a rare disease is defined as one affecting <5 per 10,000 people, whereas in the United States a disease is considered rare if it affects fewer than 200,000 people nationally.